Maria DErmit

Dr. Maria DErmit


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Developmental Cell
Verified
Journal Article
Open access
MDMaria DErmit
Maria DErmit
MDMartin Dodel
Martin Dodel
FLFlora C.Y. Lee
Flora C.Y. Lee
MAMuhammad S. Azman
Muhammad S. Azman
HSHagen Schwenzer
Hagen Schwenzer
FMFaraz K. Mardakheh
Faraz K. Mardakheh
Translation of ribosomal protein-coding mRNAs (RP-mRNAs) constitutes a key step in ribosome biogenesis, but the mechanisms that modulate RP-mRNA translation in coordination with other cellular processes are poorly defined. Here, we show that subcellular localization of RP-mRNAs acts as a key regulator of their translation during cell migration. As cells migrate into their surroundings, RP-mRNAs localize to the actin-rich cell protrusions. This localization is mediated by La-related protein 6 (LARP6), an RNA-binding protein that is enriched in protrusions. Protrusions act as hotspots of translation for RP-mRNAs, enhancing RP synthesis, ribosome biogenesis, and the overall protein synthesis in migratory cells. In human breast carcinomas, epithelial-to-mesenchymal transition (EMT) upregulates LARP6 expression to enhance protein synthesis and support invasive growth. Our findings reveal LARP6-mediated mRNA localization as a key regulator of ribosome biogenesis during cell migration and demonstrate a role for this process in cancer progression downstream of EMT.

14 May 2021 in Science
Verified
Journal Article
Closed access
PDF file
LFLisa Fish
Lisa Fish
MKMatvei Khoroshkin
Matvei Khoroshkin
ANAlbertas Navickas
Albertas Navickas
KGKristle Garcia
Kristle Garcia
BCBruce Culbertson
Bruce Culbertson
HGHani Goodarzi
Hani Goodarzi
Characterizing a cancer spliceosome: Cells undergo many genomic changes as they progress toward metastatic cancer. One aspect of this change is to RNA expression and splicing isoforms, but how these differences affect tumor progression is not well characterized. Fish et al. developed a computational framework called pyTEISER that identifies structural cis-regulatory elements that control diverse types of RNA regulation. Applying pyTEISER to models of breast cancer metastasis, they discovered an RNA short-stem-loop element that forms a “structural splicing enhancer” that acts in cis to regulate alternative splicing of RNA transcripts. One of these interactions encompasses the RNA-binding protein SNRPA1 and results in alternative exon inclusion that affects metastatic capacity in xenograft models. Thus, RNA element binding may play a role in splicing regulation and is potentially an important component of the cis-splicing code. Science , this issue p. eabc7531

12 October 2017 in Molecular BioSystems
Verified
Journal Article
Open access
PDF file
MDMaria DErmit
Maria DErmit
MDMartin Dodel
Martin Dodel
FMFaraz K. Mardakheh
Faraz K. Mardakheh
Regulation of protein translation constitutes a crucial step in control of gene expression. In comparison to transcriptional regulation, however, translational control has remained a significantly under-studied layer of gene expression. This trend is now beginning to shift thanks to recent advances in next-generation sequencing, proteomics, and microscopy based methodologies which allow accurate monitoring of protein translation rates, from single target messenger RNA molecules to genome-wide scale studies. In this review, we summarize these recent advances, and discuss how they are enabling researchers to study translational regulation in a wide variety of in vitro and in vivo biological systems, with unprecedented depth and spatiotemporal resolution.

13 July 2021 in Science Signaling
Verified
Journal Article
Closed access
PDF file
MMMònica B. Mendoza
Mònica B. Mendoza
SGSara Gutierrez
Sara Gutierrez
RORaúl Ortiz
Raúl Ortiz
DMDavid F. Moreno
David F. Moreno
MDMaria DErmit
Maria DErmit
CGCarme Gallego
Carme Gallego
Phosphorylation of eEF1A2 coordinates a transient pause in protein synthesis with cytoskeletal remodeling for synaptic plasticity.

19 December 2016 in Oncogene
Verified
Journal Article
Open access
PDF file
MDMaria DErmit
Maria DErmit
PCPedro Casado
Pedro Casado
VRV Rajeeve
V Rajeeve
EWE H Wilkes
E H Wilkes
DFD E Foxler
D E Foxler
PCPedro Rodriguez Cutillas
Pedro Rodriguez Cutillas
Compounds targeting phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR) signaling are being investigated in multiple clinical settings, but drug resistance may reduce their benefit. Compound rechallenge after drug holidays can overcome such resistance, yet little is known about the impact of drug holidays on cell biochemistry. We found that PI3K inhibitor (PI3Ki)-resistant cells cultured in the absence of PI3Ki developed a proliferative defect, increased oxygen consumption and accumulated reactive oxygen species (ROS), leading to lactate production through hypoxia-inducible factor-1α. This metabolic imbalance was reversed by mammalian target of rapamycin complex 1 (mTORC1) inhibitors. Interestingly, neither AKT nor c-MYC was involved in mediating the metabolic phenotype, despite the latter contributing to resistant cells’ proliferation. These data suggest that an AKT-independent PI3K/mTORC1 axis operates in these cells. The excessive ROS hampered cell division, and the metabolic phenotype made resistant cells more sensitive to hydrogen peroxide and nutrient starvation. Thus, the proliferative defect of PI3Ki-resistant cells during drug holidays is caused by defective metabolic adaptation to chronic PI3K/mTOR pathway inhibition. This metabolic imbalance may open the therapeutic window for challenge with metabolic drugs during drug holidays.

1 January 2020 in Development
Verified
Journal Article
Open access
PDF file
HHHoi Ting A. Hau
Hoi Ting A. Hau
OOOluwaseun Ogundele
Oluwaseun Ogundele
AHAndrew H. Hibbert
Andrew H. Hibbert
CMClinton A. L. Monfries
Clinton A. L. Monfries
KEKatherine Exelby
Katherine Exelby
SHSimon M. Hughes
Simon M. Hughes
La-related protein6 (Larp6) is a conserved RNA binding protein found across eukaryotes that has been suggested to regulate collagen biogenesis, muscle development, ciliogenesis and various aspects of cell proliferation and migration. Zebrafish have two Larp6 family genes, larp6a and larp6b. In situ hybridisation revealed significant expression of both genes in early embryos, followed by decline of larp6b mRNA by gastrulation stages, whereas larp6a mRNA showed widespread low-level expression throughout the first few days of life. To test the role of Larp6 proteins, genome editing generated predicted nonsense mutations in the first coding exon of each gene, and breeding yielded viable and fertile single and double homozygous mutants. Contrary to expectation, analysis of muscle structure revealed no defects and mutant fish grew and behaved indistinguishably from heterozygous or wild type siblings. No phenotypes similar to collagen or ciliogenesis mutants were observed. Zygotic mutants lacking all wild type Larp6 activity displayed no apparent phenotype and were viable and fertile. However, larp6a mutant females produced defective eggs with chorions that failed to elevate fully and were fragile. Eggs from larp6b single mutant females showed minor chorion defects, but chorions from eggs laid by larp6a;larp6b double mutant females were more defective than those from larp6a single mutant females. Electron microscopy revealed defective chorionogenesis during oocyte development. Nevertheless, maternal zygotic single and double mutants were viable and fertile despite defective chorions and misshapen and constricted early embryogenesis. Mass spectrometry analysis of chorions provided an initial description of chorion protein composition and revealed significant reductions in a subset of zona pellucida and lectin-type proteins between wild type and mutant chorions that paralleled the severity of the phenotype. We conclude that Larp6 proteins are required for normal oocyte development, chorion formation and egg activation.